Anastasis Biotec
Biotechnology
London, City of, United Kingdom
4 employees
- Employees
- 4
- Contacts
- 1
- Emails
- 1
- Phones
- 1
Anastasis Biotec Overview
- Headquarters
- London, City of, United Kingdom
- Website
- anastasisbiotec.com
- Industry
- Biotechnology
- Employees
- 4
- Funding
- 298.7K
Keywords
About Anastasis Biotec
Anastasis’ technology relates to a novel treatment applicable to many cancers. These cancers depend on rogue cells multiplying uncontrollably caused by DNA abnormalities (mutations) in important pathways involved in the generation of cancer and cancer stem cells. When there are mutations in these pathways, cancer cells and cancer stem cells, run rogue, multiply and spread uncontrollably.
Anastasis Biotec Contact Details
- People in AeroLeads
- 3
- With contact data
- 1
- Email contacts
- 1
- 33.3% coverage
- Phone contacts
- 1
- 33.3% coverage
Anastasis Biotec Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Raymond Moellering | Professor at University of Chicago | Greater Chicago Area, United States |
Email
Phone
|
| Agamemnon Epenetos | Chairman and CEO at Anastasis Biotec Ltd | London, England, United Kingdom |
View
|
| Mahendra Deonarain | Chief Executive Officer at Antikor |
View
|
Employees by Management Level
Executive
2 profiles
Individual contributor
1 profile
Compare Similar Companies to Anastasis Biotec
Nimbus Therapeutics
Biotechnology Research
Evozyne
Biotechnology
Vanqua Bio
Biotechnology Research
Grove Biopharma, Inc.
Biotechnology Research
cTRL Therapeutics
Biotechnology Research
CiRC Biosciences
Biotechnology Research
Kojin Therapeutics
Biotechnology Research
ReAx Biotechnologies
Biotechnology Research
ClostraBio, Inc
Biotechnology Research
Oncovalent Therapeutics
Biotechnology Research